These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 15059112)

  • 1. Contact dermatitis from topical bimatoprost.
    Sodhi PK; Verma L; Ratan SK
    Contact Dermatitis; 2004 Jan; 50(1):50. PubMed ID: 15059112
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of latanoprost, bimatoprost, and travoprost on circadian variation of intraocular pressure in patients with open-angle glaucoma.
    Yildirim N; Sahin A; Gultekin S
    J Glaucoma; 2008; 17(1):36-9. PubMed ID: 18303382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypertrichosis of vellus hairs of the malar region after unilateral treatment with bimatoprost.
    Hart J; Shafranov G
    Am J Ophthalmol; 2004 Apr; 137(4):756-7. PubMed ID: 15059720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased high-density lipoprotein serum levels associated with topical bimatoprost therapy.
    Steinhäuser SL
    Optometry; 2006 Apr; 77(4):177-9. PubMed ID: 16567279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the ocular hypotensive effects of bimatoprost and timolol-dorzolamide combination in patients with elevated intraocular pressure: a 6-month study.
    Ozturk F; Ermis SS; Inan UU
    Acta Ophthalmol Scand; 2007 Feb; 85(1):80-3. PubMed ID: 17244215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Latanoprost 0.005% versus bimatoprost 0.03% in primary open-angle glaucoma patients.
    Konstas AG; Katsimbris JM; Lallos N; Boukaras GP; Jenkins JN; Stewart WC
    Ophthalmology; 2005 Feb; 112(2):262-6. PubMed ID: 15691561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of bimatoprost for the treatment of open-angle glaucoma and ocular hypertension: a three-month, open-label study in community-based practices in Thailand.
    Wanichwecha-Rungruang B; Iemsomboon W
    J Med Assoc Thai; 2005 Sep; 88(9):1228-35. PubMed ID: 16536109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topical prostaglandin F(2alpha) analog induced poliosis.
    Chen CS; Wells J; Craig JE
    Am J Ophthalmol; 2004 May; 137(5):965-6. PubMed ID: 15126178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contact dermatitis caused by latanoprost-containing eye drops with good tolerance to bimatoprost eye drops.
    Pérez-Rodríguez E; González-Pérez R; Poza P; Feliciano L; López-Correcher B; Matheu V
    Contact Dermatitis; 2008 Jun; 58(6):370-1. PubMed ID: 18503690
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison of the effects of bimatoprost and a fixed combination of latanoprost and timolol on circadian intraocular pressure.
    Rossetti L; Karabatsas CH; Topouzis F; Vetrugno M; Centofanti M; Boehm A; Viswanathan A; Vorwerk C; Goldblum D
    Ophthalmology; 2007 Dec; 114(12):2244-51. PubMed ID: 17459480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Feasibility and efficacy of a mass switch from latanoprost to bimatoprost in glaucoma patients in a prepaid Health Maintenance Organization.
    Law SK; Song BJ; Fang E; Caprioli J
    Ophthalmology; 2005 Dec; 112(12):2123-30. PubMed ID: 16225924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Periocular cutaneous pigmentary changes associated with bimatoprost use.
    Galloway GD; Eke T; Broadway DC
    Arch Ophthalmol; 2005 Nov; 123(11):1609-10. PubMed ID: 16286629
    [No Abstract]   [Full Text] [Related]  

  • 13. The clinical impact and incidence of periocular pigmentation associated with either latanoprost or bimatoprost therapy.
    Sharpe ED; Reynolds AC; Skuta GL; Jenkins JN; Stewart WC
    Curr Eye Res; 2007 Dec; 32(12):1037-43. PubMed ID: 18085467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of the combination of bimatoprost and latanoprost on intraocular pressure in primary open angle glaucoma: a randomised clinical trial.
    Doi LM; Melo LA; Prata JA
    Br J Ophthalmol; 2005 May; 89(5):547-9. PubMed ID: 15834081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and effectiveness of topical bimatoprost.
    Mikelberg FS
    Can J Ophthalmol; 2009 Apr; 44(2):209; author reply 209. PubMed ID: 19491959
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparison of the effects of latanoprost, travoprost, and bimatoprost on circadian intraocular pressure in patients with glaucoma or ocular hypertension.
    Orzalesi N; Rossetti L; Bottoli A; Fogagnolo P
    Ophthalmology; 2006 Feb; 113(2):239-46. PubMed ID: 16458092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two new ophthalmic solutions enter glaucoma market.
    Am J Health Syst Pharm; 2001 Jun; 58(12):1080, 1086. PubMed ID: 11449848
    [No Abstract]   [Full Text] [Related]  

  • 18. Conjunctival hyperemia associated with bimatoprost use: a histopathologic study.
    Leal BC; Medeiros FA; Medeiros FW; Santo RM; Susanna R
    Am J Ophthalmol; 2004 Aug; 138(2):310-3. PubMed ID: 15289152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypertrichosis of the eyelashes caused by bimatoprost.
    Tosti A; Pazzaglia M; Voudouris S; Tosti G
    J Am Acad Dermatol; 2004 Nov; 51(5 Suppl):S149-50. PubMed ID: 15577756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flare-up rates with bimatoprost therapy in uveitic glaucoma.
    Fortuna E; Cervantes-Castañeda RA; Bhat P; Doctor P; Foster CS
    Am J Ophthalmol; 2008 Dec; 146(6):876-82. PubMed ID: 19027422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.